Associations between Plasma Metabolites, Dementia and Modifiable Risk Factors

Abstract

Background: Metabolic dysfunction is increasingly recognized as an early contributor to the pathophysiology of dementia. Identifying blood‐based biomarkers associated with preclinical disease changes may provide valuable insights into early disease mechanisms and potential intervention strategies.